Giant Cell Temporal Arteritis

Slide 1 · Giant Cell (Temporal) Arteritis

Chronic, frequently granulomatous inflammation of medium- and large-sized arteries

Cranial ischemia and preventable visual catastrophe connect morphology to clinical urgency

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Locate giant cell arteritis within the spectrum of vasculitis.

Explain its immune hypothesis and arterial-wall injury.

Recognize active and healed arterial morphology.

Integrate presentation, biopsy limitations, and visual risk.

Slide 3 · Large-vessel vasculitis: The parent category

The aorta and major branches are typically involved.

The two principal forms are giant cell arteritis and Takayasu arteritis.

The vessel-size label describes predominance, not an absolute boundary.

Slide 4 · Giant cell arteritis: Defining pathology

Chronic arterial inflammation

Wall remodeling / injury

Luminal narrowing

Tissue ischemia

Chronic inflammation of arteries, classically granulomatous.

Predominant involvement of medium- and large-caliber arteries.

Arterial stenosis and ischemic injury follow wall inflammation and remodeling.

Slide 5 · “Temporal arteritis” is an incomplete name

Temporal artery

Accessible for biopsy

Other cranial arteries

Potential visual and neurologic consequences

Aorta / major branches

Recognized large-vessel involvement

The superficial temporal artery is a useful diagnostic biopsy site.

Temporal arteries are not the only vulnerable vessels.

The systemic disease can also affect the aorta and other branches.

Slide 6 · Giant cell arteritis crosses vessel-size categories

Large- and medium-sized arteries

Aorta

Cranial branches

Medium / smaller arteries

Despite its large-vessel classification, medium and even smaller arteries can be involved.

Do not equate the diagnostic biopsy vessel with the full anatomic extent.

Slide 7 · Epidemiologic context: Advanced age

The condition is rare before 50 years of age.

It as the commonest vasculitis of elderly adults in the United States and Europe.

Age is useful context—not a stand-alone tissue diagnosis.

Slide 8 · Preferred distribution includes head arteries

Cranial arterial disease

Temporal

Vertebral

Ophthalmic

Cranial artery involvement is especially characteristic.

The temporal, vertebral, and ophthalmic arterial territories are clinically important.

Symptoms depend on which involved artery becomes flow-limiting.

Slide 9 · Aortic disease belongs to the same entity

Giant cell arteritis

Aorta

Major branches

Cranial arteries

Giant cell arteritis can involve the aorta: Giant cell aortitis.

A cranial presentation does not imply disease is confined to the head.

The large-vessel framework explains its overlap with Takayasu arteritis.

Slide 10 · Why the temporal artery matters diagnostically

Superficial location facilitates tissue sampling.

The sampled segment can reveal characteristic inflammation and elastic injury.

Biopsy accessibility—not exclusive disease localization—explains the historical name.

Slide 11 · Clinical priority: Protect vision

Ophthalmic artery involvement

Reduced ocular perfusion

Sudden visual disturbance

Potential permanent blindness

Ophthalmic arterial inflammation can abruptly compromise ocular blood flow.

The resulting visual deficit may be permanent.

Prompt recognition and treatment when the disease is suspected.

Slide 12 · Pathogenesis remains an immune hypothesis

The implicated vessel-wall antigen has not been identified.

A T-cell–mediated immune response is considered central.

Avoid presenting the initiating antigen as established.

Slide 13 · The proposed initiating event

Unidentified vascular antigen?

T-cell immune response

Inflammatory injury

An unknown antigen in the vessel wall is postulated.

The resulting response involves T lymphocytes and inflammatory mediators.

The model is supported by morphology and immune associations—not direct antigen identification.

Slide 14 · T cells are part of the arterial infiltrate

Both CD4⁺ and CD8⁺ T lymphocytes are described.

The cellular infiltrate is within the arterial wall, rather than a purely luminal process.

T-cell involvement supports immune-mediated rather than purely degenerative injury.

Slide 15 · Macrophages help define the lesion

Macrophages accompany T lymphocytes in affected vessel walls.

Macrophage-rich inflammation contributes to the granulomatous phenotype.

The mixture of inflammatory cells explains why giant cells are not mandatory.

Slide 16 · IFN-γ is an implicated cytokine

Interferon-γ as a relevant proinflammatory mediator.

Its involvement is consistent with T-cell/macrophage-rich inflammation.

A detailed molecular cascade is not resolved in the supplied source.

Slide 17 · IL-17 is an implicated cytokine

Interleukin-17 is also highlighted in the proposed pathogenesis.

It adds an inflammatory signaling component to the T-cell model.

The textbook does not claim that a single cytokine accounts for all pathology.

Slide 18 · Antiendothelial antibodies may contribute

Antiendothelial-cell antibodies are noted as possible contributors.

Their presence should not be confused with a disease-specific diagnostic test.

The supplied excerpt provides no cutoff or assay performance metric.

Slide 19 · Granulomatous inflammation: A tissue response

The classic pattern is granulomatous inflammation of arterial media.

Multinucleated giant cells are one possible component.

The histologic distribution is strongly associated with elastic lamina injury.

Slide 20 · Why an immune etiology is favored

Tissue pattern

Granulomatous arteritis

Host association

MHC class II association

Treatment response

Steroid responsiveness

Granulomatous wall inflammation.

Association with particular MHC class II haplotypes.

Clinical responsiveness to corticosteroid therapy.

Slide 21 · What is known—and not known—about selectivity

Cranial arterial predilection is well recognized.

The reason for the head-vessel preference remains unexplained.

Distinct embryologic vascular origins and antigens are proposed, not proven.

Slide 22 · Pathogenesis and damage: Integrated model

Immune activation

T cells / macrophages

Elastic injury + intimal growth

Luminal stenosis

The initiating vascular antigen is unknown.

Inflammatory and remodeling processes converge on the internal elastic lamina and intima.

Slide 23 · Inflammation and stenosis are linked

Wall inflammation

Intimal thickening

Narrow lumen

Ischemic symptoms

An inflamed arterial wall develops structural alterations.

Intimal thickening is particularly important for narrowing the lumen.

This converts immune injury into impaired regional perfusion.

Slide 24 · Mechanism is not equivalent to a biomarker panel

MHC associations and cytokines are mechanistic evidence.

The defining diagnosis in the supplied section relies on morphology from biopsy.

No specific cytokine or antibody assay is endorsed as a stand-alone diagnostic criterion.

Slide 25 · Normal muscular artery: Orientation

A central lumen is separated from media by the intimal compartment.

The internal elastic lamina marks the intima–media interface.

Adventitia surrounds the media.

Schematic — normal arterial wall

Layers not drawn to scale.

Slide 26 · Active arteritis: The histologic archetype

Inflammation is concentrated in the arterial wall.

Granulomatous inflammation typically involves the media.

Elastic lamina damage and intimal expansion can coexist.

Schematic — active arteritis

Immune dots are illustrative, not cells on a slide.

Slide 27 · Intimal thickening is a key lesion

The intima may expand conspicuously in affected segments.

Intimal expansion decreases luminal cross-sectional area.

This structural change helps explain symptoms of arterial insufficiency.

Schematic — active arteritis

Thick intima → reduced lumen (schematic).

Slide 28 · Luminal narrowing links anatomy to symptoms

Thickened arterial intima

Reduced luminal caliber

Lower distal perfusion

Tissue dysfunction

Progressive wall remodeling restricts downstream blood supply.

Symptoms depend on the artery and target tissue.

Cranial artery disease is dangerous because ocular injury can be permanent.

Slide 29 · Thrombosis may complicate an inflamed artery

Occasional thromboses in affected segments.

Thrombus can further reduce a lumen already narrowed by intimal thickening.

Thrombosis is not required to identify giant cell arteritis.

Slide 30 · Granulomatous inflammation is usually medial

A classic active lesion contains granulomatous inflammation in the media.

The internal elastic membrane is an important spatial focus.

The lesion should be interpreted by distribution and vessel injury—not giant cells alone.

Schematic — active arteritis

Simplified medial inflammatory distribution.

Slide 31 · The internal elastic lamina is a diagnostic landmark

Active disease may show elastic membrane disruption.

An elastic tissue stain can highlight loss of elastic continuity.

Textbook Figure 11.23 describes this relationship; The image was not supplied.

Schematic — active arteritis

Broken blue contour represents elastic injury.

Slide 32 · Elastic fragmentation and inflammation co-localize

Classic granulomatous inflammation is centered near the internal elastic membrane.

Fragmentation is an important associated finding.

Interpret loss of elastic continuity with the rest of the wall morphology.

Slide 33 · Cells described in active lesions

T lymphocytes

Both CD4⁺ and CD8⁺ populations described

Macrophages

Core component of arterial-wall inflammation

Giant cells

Characteristic but not universally detectable

CD4⁺ T lymphocytes.

CD8⁺ T lymphocytes.

Macrophages; Multinucleated giant cells may be present.

Slide 34 · Giant cells: Characteristic, not compulsory

Approximately 75% of adequately biopsied specimens contain multinucleated giant cells in the Robbins account.

Absence of giant cells is not a valid exclusion rule.

Overall arterial-wall morphology remains decisive.

Slide 35 · Classic morphology can be incomplete

Granulomas may be sparse or absent.

Multinucleated giant cells may be sparse or absent.

A diagnosis should integrate wall inflammation, elastic damage, and intimal remodeling.

Slide 36 · Skip lesions: Inflammation is discontinuous

Longitudinal involvement of a single artery (schematic)

Uninvolved

Inflamed

Uninvolved

Inflamed

Uninvolved

Biopsy location and length determine whether a focal lesion is sampled.

Changes are patchy along the longitudinal course of an involved artery.

A sample from an uninvolved interval can miss the lesion.

This sampling property explains some negative biopsies.

Slide 37 · Specimen length matters in a patchy disease

Longitudinal involvement of a single artery (schematic)

Uninvolved

Inflamed

Uninvolved

Inflamed

Uninvolved

Biopsy location and length determine whether a focal lesion is sampled.

Adequate longitudinal sampling increases the opportunity to encounter inflamed segments.

The source text has an OCR ambiguity in its numerical length symbol.

No precise minimum length is asserted here without the original PDF.

Slide 38 · Biopsy interpretation requires whole-wall assessment

Look for inflammation in media and surrounding arterial compartments.

Evaluate the internal elastic lamina and intima.

Determine whether features represent active disease or healed remodeling.

Slide 39 · Active and healed stages are morphologically different

Component

Active lesion

Healed lesion

Inflammation

Often granulomatous; T cells/macrophages

May no longer be conspicuous

Media

Inflammatory injury

Attenuation and scarring

Internal elastic lamina

Fragmentation

Extensive residual fragmentation

Intima

Thickening / stenosis

Persistent thickening

Slide 40 · Healed disease: Medial attenuation and scarring

The media may become thinned and fibrotic.

Active inflammatory cells need not remain abundant.

Healed injury must be recognized as structural remodeling rather than active granuloma alone.

Schematic — healed remodeling

Gray wall denotes scar/attenuation, not a real stain.

Slide 41 · Healed disease: Persistent intimal thickening

Intimal thickening persists after acute inflammatory activity.

The resulting stenosis can outlast visible inflammation.

The arterial wall therefore records the history of injury.

Schematic — healed remodeling

Structural narrowing may remain.

Slide 42 · Healed disease: Adventitial fibrosis

Adventitial fibrosis is an additional healing feature.

This may coexist with medial scarring and elastic lamina loss.

The diagnosis rests on the combination and anatomic context.

Slide 43 · Healed disease: Extensive elastic loss

The Robbins description includes fragmentation over more than 30% of the elastic lamina circumference.

This accompanies medial scarring, intimal thickening, and adventitial fibrosis.

No single threshold should be detached from the full histologic pattern.

Slide 44 · An active–healed continuum

Active inflammation

Elastic injury

Remodeling / fibrosis

Healed arterial lesion

Active granulomatous medial injury can resolve into structural scarring.

Elastic fragmentation and intimal thickening bridge the two descriptions.

The schematic depicts conceptual evolution—not a measured patient time course.

Slide 45 · What Figure 11.23 would demonstrate

H&E: Giant cells and degenerating internal elastic membrane in active disease.

Elastic tissue stain: Focal lamina destruction and intimal thickening.

Clinical photograph: Thickened, nodular, tender temporal artery.

Slide 46 · Morphologic pitfalls at the microscope

Treating absence of giant cells as exclusion.

Ignoring focal distribution within the submitted artery.

Failing to assess elastic membrane damage and healed change.

Overinterpreting one isolated feature without clinical context.

Slide 47 · Clinical presentations: Systemic or localized

Constitutional

Fever, fatigue, weight loss

Cranial pain

Facial pain or temporal headache

Ocular

Diplopia through complete visual loss

Some patients present only with nonspecific constitutional symptoms.

Others present with focal cranial arterial pain.

Abrupt ocular symptoms define a particularly high-risk phenotype.

Slide 48 · Constitutional symptoms

Fever may be the presenting clue.

Fatigue and weight loss may dominate the early complaint.

These findings alone are nonspecific; Arterial features guide suspicion.

Slide 49 · Headache and facial pain

Headache is often most intense along the superficial temporal artery.

Facial pain may be part of the cranial presentation.

The anatomic distribution helps connect symptoms to the artery.

Slide 50 · The temporal artery may be tender

Palpation may be painful along the superficial temporal artery.

Robbins Figure 11.23 describes a thickened, nodular, tender arterial segment.

The palpable lesion is a clinical correlate of arterial inflammation.

Slide 51 · Ophthalmic arterial disease

Arterial inflammation

Ophthalmic involvement

Visual symptoms

Vision-threatening injury

Visual symptoms reflect involvement of the ophthalmic arterial circulation.

Onset may be abrupt.

Because deficits can be permanent, visual symptoms are a high-priority warning.

Slide 52 · Diplopia is an important ocular symptom

Diplopia lies within the reported ocular presentation spectrum.

It can herald arterial disease rather than benign isolated discomfort.

Ocular symptoms require urgent assessment in this clinical context.

Slide 53 · Vision loss can be sudden and permanent

The severe end of the ocular spectrum is complete loss of vision.

Abrupt ocular symptoms in about half of patients.

This makes giant cell arteritis a time-sensitive clinicopathologic diagnosis.

Slide 54 · Cranial symptoms and histology fit together

Wall inflammation

Stenosis / thrombosis

Ocular ischemia

Visual deficit

Arterial wall inflammation explains tenderness.

Intimal thickening and possible thrombosis explain reduced flow.

Ophthalmic circulation involvement explains potentially irreversible deficits.

Slide 55 · Clinical–pathologic correlations

Clinical observation

Pathologic correlate

Tender temporal artery

Inflamed arterial wall

Temporal headache / facial pain

Cranial arterial involvement

Diplopia / vision loss

Ophthalmic arterial involvement with impaired perfusion

Persistent arterial dysfunction

Intimal thickening and fibrosis

Slide 56 · Recognition: The central clinical question

Is an older patient presenting with new cranial or visual symptoms?

Could the complaints reflect inflammation of cranial arteries?

Would failure to act expose the patient to permanent visual injury?

Slide 57 · Biopsy and histologic confirmation

The supplied Robbins section emphasizes temporal artery biopsy.

Typical histology links immune inflammation to elastic damage and intimal remodeling.

Clinical suspicion and specimen adequacy remain essential to interpretation.

Slide 58 · A negative biopsy cannot rule out the disease

Longitudinal involvement of a single artery (schematic)

Uninvolved

Inflamed

Uninvolved

Inflamed

Uninvolved

Biopsy location and length determine whether a focal lesion is sampled.

The lesion may be missed because involvement is patchy.

A negative specimen does not exclude disease even with otherwise adequate sampling.

Interpret the negative result against the clinical picture.

Slide 59 · Diagnostic reasoning with discordant results

Strong cranial/ocular symptoms can coexist with a negative biopsy.

Reassess the extent and representativeness of the specimen.

Avoid converting a sampling limitation into a biological exclusion.

Slide 60 · Pathologist’s integrated tissue checklist

Assess

Diagnostic question

Media

Is the infiltrate granulomatous or macrophage/T-cell rich?

Elastic lamina

Is there fragmentation, particularly near inflammation?

Intima

Is there pathologic thickening or luminal narrowing?

Healing

Is there medial scarring or adventitial fibrosis?

Slide 61 · Clinical urgency does not depend on a perfect sample

Delay matters when the ophthalmic arterial circulation is at risk.

Robbins stresses prompt diagnosis and treatment.

Histologic sampling limitations must be kept in view during management.

Slide 62 · Therapeutic implication

Corticosteroid responsiveness is part of the evidence for an immune mechanism.

Prompt treatment is important because ophthalmic injury may be permanent.

The extracted textbook statement about anti-TNF treatment is not presented as a current guideline recommendation.

Slide 63 · The closest comparator: Takayasu arteritis

Feature

Giant cell arteritis

Takayasu arteritis

Typical age

Older than 50 years

Younger than 50 years

Histologic category

Granulomatous large-vessel arteritis

Granulomatous large-vessel arteritis

Characteristic clue

Temporal/cranial involvement

Aortic arch / great vessels; weak upper-limb pulses

Overlap

Can involve aorta

Shares histologic features with GCA

Slide 64 · Why histology alone may not separate them

Both giant cell arteritis and Takayasu arteritis may be granulomatous.

Both can involve the aorta and major branches.

Age and clinical–anatomic pattern are important discriminatory information.

Slide 65 · Takayasu: Aortic arch and pulse phenotype

Aortic arch arteritis

Fibrous thickening

Branch stenosis

Weak arm pulses

Transmural fibrous thickening affects the aorta and great vessels.

Major branch stenosis explains reduced upper-extremity pulses.

This clinical pattern contrasts with the typical cranial GCA presentation.

Slide 66 · Vessel-size classification avoids false equivalence

Category

Predominant arteries

Example in Robbins

Large vessel

Aorta, great arteries

GCA; Takayasu

Medium vessel

Main visceral arteries and branches

Polyarteritis nodosa

Small vessel

Arterioles, capillaries, venules

Microscopic polyangiitis

Slide 67 · Case 1: New cranial pain in an older adult

A 72-year-old patient develops persistent unilateral temporal headache and tenderness over the superficial temporal artery. No laboratory data are supplied.

Which disease should enter the differential immediately?

State the leading pathology-based concern.

Identify the arterial lesion that could generate symptoms.

Slide 68 · Case 1: Pathology-based explanation

Age and cranial arterial symptoms are compatible with giant cell arteritis.

The inflamed wall can be tender; Intimal expansion can restrict flow.

A biopsy may demonstrate granulomatous medial disease and elastic injury.

Slide 69 · Case 2: Abrupt visual symptoms

An older patient with recent temporal headache reports newly developed diplopia and rapidly progressive visual difficulty.

Which arterial territory makes this presentation urgent?

Identify the complication at risk of becoming permanent.

Explain why delay in assessment is unsafe.

Slide 70 · Case 2: Link ocular symptoms to arterial injury

Involvement of the ophthalmic circulation can impair ocular perfusion.

Symptoms span diplopia to complete vision loss.

Urgent management is required because visual loss may be permanent.

Slide 71 · Case 3: A negative temporal artery biopsy

A patient has a strongly suggestive cranial presentation, but the sampled temporal artery shows no diagnostic inflammation.

How should the biopsy result be interpreted?

Explain the possible false-negative mechanism.

State whether a negative biopsy logically excludes the disease.

Slide 72 · Case 3: Sampling and interpretation

Longitudinal involvement of a single artery (schematic)

Uninvolved

Inflamed

Uninvolved

Inflamed

Uninvolved

Biopsy location and length determine whether a focal lesion is sampled.

Inflammatory changes can be discontinuous along the same artery.

A sample may contain only an uninvolved interval.

Clinical and pathologic evidence must therefore be integrated.

Slide 73 · Case 4: Giant cells are not seen

The absence of giant cells alone is insufficient to exclude giant cell arteritis.

Seek medial inflammation, elastic disruption, and intimal thickening.

Remember that classic lesions do not always contain identifiable granulomas.

Slide 74 · Case 5: Scarred arterial wall

Medial attenuation and scarring suggest a healed phase.

Associated intimal thickening, elastic loss, and adventitial fibrosis support prior injury.

Do not require conspicuous active granulomas in every healed segment.

Schematic — healed remodeling

Hypothetical healed-lesion pattern.

Slide 75 · Integrated diagnostic concept

Clinical suspicion

Arterial-wall examination

Morphologic interpretation

Integrated assessment

Clinical context: Older patient with cranial or ocular symptoms.

Pathology: Segmental medial inflammation and elastic disruption.

Consequence: Intimal remodeling and ischemic manifestations.

Limitation: A negative sample cannot exclude patchy disease.

Slide 76 · High-yield synthesis

GCA is a chronic, often granulomatous, immune-mediated large-vessel vasculitis.

Temporal artery accessibility must not obscure systemic arterial distribution.

Elastic lamina injury, intimal thickening, and active/healed wall changes are central.

Visual symptoms demand urgency; Patchy biopsies can be falsely negative.

Slide 77 · Primary source and scope

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026).

Chapter 11, Blood Vessels: “Giant Cell (Temporal) Arteritis,” pp. 464–465.

Parent context: noninfectious / large-vessel vasculitis; adjacent Takayasu section.

Schematic drawings are original editable teaching diagrams—not reproduced histology.